Search - tctmd.com

Displaying 1 - 20 of 76

Sort: Relevancy | Date

News Daily News

Registry Data Show Rise and Fall of Bivalirudin vs Heparin for Primary PCI

Yael L. Maxwell

November 11, 2016

News Daily News

At 3 Years Post-TAVR, Valve Performance Holds Steady and Most Mortality Is Noncardiac: FRANCE 2 Registry

Caitlin E. Cox

October 04, 2016

News Daily News

比伐卢定和普通肝素对有无 ST 段抬高的 ACS 患者没有任何差异：MATRIX

Shelley Wood

October 03, 2016

News Daily News

No Differences Between Bivalirudin, Unfractionated Heparin in ACS Patients With or Without ST Elevation: MATRIX

Shelley Wood

October 03, 2016

News Daily News

MATRIX: No Hay Diferencias entre Bivalirudina y Heparina No Fraccionada en Pacientes SCA Con o Sin Elevación del Segmento ST

Shelley Wood

October 03, 2016

News Daily News

Stroke Risk With TAVR: In-Depth Review of PARTNER and CoreValve Data Reveals Opportunities and Unknowns

Shelley Wood

September 13, 2016

News Daily News

‘Reassuring’ 18-Month Results Seen With Absorb BVS, but Longer-Term Follow-up Still Needed

Michael O'Riordan

August 01, 2016

News Daily News

Another Meta-Analysis Supports Prolonged Bivalirudin Use in STEMI, but Is Contemporary PCI Reflected?

Yael L. Maxwell

July 27, 2016

News Daily News

New Analysis Bolsters Evidence Backing the Safety of Multivessel PCI in STEMI

Todd Neale

June 29, 2016

News Daily News

Prolonged Full-Dose Bivalirudin May Preserve Bleeding Benefit Without Upping Thrombotic Events After STEMI, Meta-Analysis Suggests

Yael L. Maxwell

June 20, 2016

News Daily News

MitraClip for Obstructive Hypertrophic Cardiomyopathy? Small Series Raises Hopes

Shelley Wood

June 14, 2016

News Daily News

SYNTAX Score II Added to Modern PCI Translates Into Gains for Patients With Three-Vessel Disease

Caitlin E. Cox

May 26, 2016

News Daily News

Signs of Cardioprotection Seen in Acute STEMI Patients Receiving IV Beta-blocker Post-PCI

Caitlin E. Cox

February 03, 2016

News Daily News

Symptom Duration May Be More Important Than D2B for STEMI, HORIZONS-AMI Substudy Suggests

Yael L. Maxwell

January 05, 2016

News Daily News

Registry Charts Trends in Mechanical Circulatory Support During PCI

L.A. McKeown

September 14, 2015

News Daily News

A-fib, Whether Preexisting or New-Onset, Tied to Poor Outcomes in TAVR

Yael L. Maxwell

August 30, 2015

News Daily News

No Disadvantage for 2-Stent Strategy in Bifurcation Lesions With Second-Generation DES

Yael L. Maxwell

August 26, 2015

News Daily News

Real-World LVAD Use Promising in Patients Otherwise Considered Too Sick for PCI

L.A. McKeown

August 24, 2015

News Daily News

COMPARE: EES Maintains Advantage Over PES at 5 Years

Salynn Boyles

July 30, 2015

News Daily News

Registry Provides Reassurance About Rotational Atherectomy Pre-PCI

Todd Neale

July 23, 2015

Advertisement

Registry Data Show Rise and Fall of Bivalirudin vs Heparin for Primary PCI

At 3 Years Post-TAVR, Valve Performance Holds Steady and Most Mortality Is Noncardiac: FRANCE 2 Registry

比伐卢定和普通肝素对有无 ST 段抬高的 ACS 患者没有任何差异：MATRIX

No Differences Between Bivalirudin, Unfractionated Heparin in ACS Patients With or Without ST Elevation: MATRIX

MATRIX: No Hay Diferencias entre Bivalirudina y Heparina No Fraccionada en Pacientes SCA Con o Sin Elevación del Segmento ST

Stroke Risk With TAVR: In-Depth Review of PARTNER and CoreValve Data Reveals Opportunities and Unknowns

‘Reassuring’ 18-Month Results Seen With Absorb BVS, but Longer-Term Follow-up Still Needed

Another Meta-Analysis Supports Prolonged Bivalirudin Use in STEMI, but Is Contemporary PCI Reflected?

New Analysis Bolsters Evidence Backing the Safety of Multivessel PCI in STEMI

Prolonged Full-Dose Bivalirudin May Preserve Bleeding Benefit Without Upping Thrombotic Events After STEMI, Meta-Analysis Suggests

MitraClip for Obstructive Hypertrophic Cardiomyopathy? Small Series Raises Hopes

SYNTAX Score II Added to Modern PCI Translates Into Gains for Patients With Three-Vessel Disease

Signs of Cardioprotection Seen in Acute STEMI Patients Receiving IV Beta-blocker Post-PCI

Symptom Duration May Be More Important Than D2B for STEMI, HORIZONS-AMI Substudy Suggests

Registry Charts Trends in Mechanical Circulatory Support During PCI

A-fib, Whether Preexisting or New-Onset, Tied to Poor Outcomes in TAVR

No Disadvantage for 2-Stent Strategy in Bifurcation Lesions With Second-Generation DES

Real-World LVAD Use Promising in Patients Otherwise Considered Too Sick for PCI

COMPARE: EES Maintains Advantage Over PES at 5 Years

Registry Provides Reassurance About Rotational Atherectomy Pre-PCI

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content